FK-506-Alkaline Phosphatase
Catalog Number: FK5
| Precursor | FK-506 (Tacrolimus) |
| Concentration | 100 Units/ml (2000 Units/mg) |
| Form | Liquid in 7 mM PBS, pH 7.7 with 0.05% Sodium Azide |
| Storage | 4° C |
| Addition Remarks | Use for EIA. Displaying high binding with Anti-FK-506 antibody for assay development with sensitivity of ~1 ng/ml |
Enzyme Immunoassay for the Determination of FK-506 in Sample Extract
Introduction
FK-506 (Tacrolimus) is a microlide lactone of fugal origin with potent immunosuppressive properties. FK-506 is used for primary or rescue immunosuppressant in patients after solid organ transplantation. Clinically relevant FK-506 side effects are nephrotoxicity, neurotoxicity, diabetes mellitus and hypertension. Most of these side effects are more closely related to FK-506 blood levels than dosage, therefore therapeutic drug monitoring of FK-506 levels is a prerequisite for therapy.
Principle of FK-506 Determination
The enzyme immunoassay for FK-506 is based on the competition between the FK-506 to be assayed and the FK-506-Alkaline Phosphatase conjugate, for binding to rabbit antibody directed against FK-506, coated onto microwells. The sample containing the FK-506, and the FK-506-Alkaline Phosphatase conjugate, when added to the microtiter wells, compete for binding to a limiting number of antibody sites. After incubation, each well is rinsed in order to remove non-bound components. The bound enzymatic activity is then measured by the addition of a chromogenic substrate. The intensity of the color developed is inversely proportional to the concentration of FK-506 in the sample. The concentration is calculated on the basis of a standard curve.
Reagents
Assay Procedure
Cross Reactivity
Cross react with Ascomycin. Do not cross react with Gentamicin, Neomycin, Tylosin, Sulfamethazine, Sulfadimethoxine, Zearalenone and Narasin.
FK-506 Inhibition Curve
